Leukemic hypopyon in acute myeloid leukemia

被引:7
作者
Alten, Florian [1 ]
Ehlert, Karoline [2 ]
Boehm, Michael R. [1 ]
Grenzebach, Ulrike H. [1 ]
机构
[1] Univ Munster, Dept Ophthalmol, D-48149 Munster, Germany
[2] Univ Childrens Hosp Muenster, Dept Pediat Hematol & Oncol, Munster, Germany
关键词
Acute myeloid leukemia; Leukemic hypopyon; Masquerade syndrome;
D O I
10.5301/ejo.5000177
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Leukemic hypopyon uveitis in acute myeloid leukemia (AML) is a very rare condition. We report this case of an unusual finding in a 2(1/2)-year-old boy in second remission after chemotherapy for relapsed AML. METHODS. A young patient with an AML FAB M5 in second remission developed pain, photophobia, and conjunctival injections in the right eye. Recent bone marrow aspiration showed no blast increase and recent peripheral blood sampling presented no evidence of relapse. RESULTS. The patient showed a viscous hypopyon and a myotic pupil in the right eye that was refractory to corticosteroids. Anterior chamber aspiration revealed atypical blasts similar to the leukemic cells that were found in the bone marrow aspirate at the time of systemic relapse. CONCLUSIONS. Timely anterior chamber aspiration and subsequent cytology is useful in differentiating leukemic hypopyon from true intraocular inflammation in AML patients. This is the first report about a leukemic hypopyon uveitis in AML without systemic findings of malignant cells in a child.
引用
收藏
页码:252 / 254
页数:3
相关论文
共 50 条
  • [31] Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
    Craddock, C.
    Quek, L.
    Goardon, N.
    Freeman, S.
    Siddique, S.
    Raghavan, M.
    Aztberger, A.
    Schuh, A.
    Grimwade, D.
    Ivey, A.
    Virgo, P.
    Hills, R.
    McSkeane, T.
    Arrazi, J.
    Knapper, S.
    Brookes, C.
    Davies, B.
    Price, A.
    Wall, K.
    Griffiths, M.
    Cavenagh, J.
    Majeti, R.
    Weissman, I.
    Burnett, A.
    Vyas, P.
    LEUKEMIA, 2013, 27 (05) : 1028 - 1036
  • [33] An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
    Victor Pallarès
    Ugutz Unzueta
    Aïda Falgàs
    Laura Sánchez-García
    Naroa Serna
    Alberto Gallardo
    Gordon A. Morris
    Lorena Alba-Castellón
    Patricia Álamo
    Jorge Sierra
    Antonio Villaverde
    Esther Vázquez
    Isolda Casanova
    Ramon Mangues
    Journal of Hematology & Oncology, 13
  • [34] CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
    Touzet, Lucas
    Dumezy, Florent
    Roumier, Christophe
    Berthon, Celine
    Bories, Claire
    Quesnel, Bruno
    Preudhomme, Claude
    Boyer, Thomas
    CANCER MEDICINE, 2019, 8 (03): : 1279 - 1288
  • [35] Transglutaminase 2 expression in acute myeloid leukemia: Association with adhesion molecule expression and leukemic blast motility
    Pierce, Andrew
    Whetton, Anthony D.
    Meyer, Stefan
    Ravandi-Kashani, Farhad
    Borthakur, Gautam
    Coombes, Kevin R.
    Zhang, Nianxiang
    Kornblau, Steven
    PROTEOMICS, 2013, 13 (14) : 2216 - 2224
  • [36] Two autopsy cases of pulmonary leukemic infiltration mimicking severe pneumonia in patients with acute myeloid leukemia
    Iizuka, Hiroko
    Mori, Yosuke
    Fukuda, Yasutaka
    Iwao, Noriaki
    Koike, Michiaki
    Noguchi, Masaaki
    LEUKEMIA RESEARCH REPORTS, 2021, 16
  • [37] Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia
    Ji Hyun Kwon
    Young-il Koh
    Sung-soo Yoon
    Seonyang Park
    Inho Kim
    International Journal of Hematology, 2016, 104 : 574 - 581
  • [38] Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases
    Lina Han
    Jan Jacob Schuringa
    André Mulder
    Edo Vellenga
    Annals of Hematology, 2010, 89 : 861 - 871
  • [39] Leukemic Cells Infiltrate the Ovaries Without Damaging Ovarian Reserve in an Acute Myeloid Leukemia Mouse Model
    Abazarikia, Amirhossein
    Luan, Yi
    So, Wonmi
    Becker, Michelle
    Panda, Sipra
    Swenson, Samantha A.
    Kosmacek, Elizabeth A.
    Oberley-Deegan, Rebecca E.
    Xiao, Shuo
    Hyde, Ricia Katherine
    Kim, So-Youn
    ENDOCRINOLOGY, 2025, 166 (04)
  • [40] Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
    C Craddock
    L Quek
    N Goardon
    S Freeman
    S Siddique
    M Raghavan
    A Aztberger
    A Schuh
    D Grimwade
    A Ivey
    P Virgo
    R Hills
    T McSkeane
    J Arrazi
    S Knapper
    C Brookes
    B Davies
    A Price
    K Wall
    M Griffiths
    J Cavenagh
    R Majeti
    I Weissman
    A Burnett
    P Vyas
    Leukemia, 2013, 27 : 1028 - 1036